✦ LIBER ✦

Retreatment of gefitinib in patients with non-small-cell lung cancer who previously controlled to gefitinib: A single-arm, open-label, phase II study

✍ Scribed by Oh, In-Jae; Ban, Hee-Jung; Kim, Kyu-Sik; Kim, Young-Chul

Book ID: 119320757
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 497 KB
Volume: 77
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2012.01.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective Study of Gefitinib Readminis

Prospective Study of Gefitinib Readministration After Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer Who Previously Responded to Gefitinib

✍ Tomonobu Koizumi; Toshihiko Agatsuma; Kayoko Ikegami; Toshiro Suzuki; Takashi Ko 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 322 KB

A Randomized Phase II Study of Gefitinib

A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

✍ Han, J.-Y.; Lee, S.-H.; Yoo, N. J.; Hyung, L. S.; Moon, Y. J.; Yun, T.; Kim, H. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 317 KB

First-Line Single Agent Treatment With G

First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Phase II Study

✍ Niho, S. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 124 KB

Randomized phase II study of gefitinib v

Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy

✍ Kim, Seung Tae; Uhm, Ji Eun; Lee, Jeeyun; Sun, Jong-mu; Sohn, Insuk; Kim, Seon W 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 359 KB

A phase II study of single-agent gefitin

A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer

✍ Suzuki, R; Hasegawa, Y; Baba, K; Saka, H; Saito, H; Taniguchi, H; Yamamoto, M; M 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

187 POSTER A phase II study of daily gef

187 POSTER A phase II study of daily gefitinib plus weekly paclitaxel (GP) in Taiwanese non-small cell lung cancer (NSCLC) patients who failed prior gefitinib or both gefitinib and taxane treatment

✍ C. Tsai; C. Chiu; C. Lai; J. Liu; R. Perng 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB